| |
| |
|
| Insider
Information: |
Amgen Inc |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
58,974,246 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,928,426,416 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,974,246 |
|
|
| Total
Value |
$2,928,426,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -21.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
10% Owner |
2013-06-05 |
334,126 |
2013-06-05 |
0 |
Premium* |
|
|
Kezar Life Sciences, Inc. |
KZR |
10% Owner |
2018-06-25 |
1,121,384 |
2018-06-25 |
0 |
Premium* |
|
|
Beigene Ltd |
BGNE |
10% Owner |
2021-09-10 |
18,943,802 |
|
0 |
Premium* |
|
|
Vigil Neuroscience, Inc. |
VIGL |
10% Owner |
2022-01-11 |
3,206,281 |
2022-01-11 |
0 |
Premium* |
|
|
Neumora Therapeutics, Inc. |
NMRA |
|
2023-09-19 |
35,368,653 |
2023-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NMRA |
Neumora Therapeutics, Inc... |
|
• • • |
2023-09-19 |
4 |
B |
$17.00 |
$29,999,985 |
D/D |
1,764,705 |
35,368,653 |
0.01 |
% |
|
| NMRA |
Neumora Therapeutics, Inc... |
|
• • • |
2023-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,603,948 |
33,603,948 |
0 |
- |
|
| VIGL |
Vigil Neuroscience, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,206,281 |
3,206,281 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2021-09-10 |
4 |
B |
$302.06 |
$49,999,938 |
D/D |
165,529 |
18,943,802 |
2.45 |
% |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-12-18 |
4 |
A |
$260.95 |
$6,722,504 |
D/D |
25,762 |
18,778,273 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-12-17 |
4 |
A |
$260.54 |
$19,442,507 |
D/D |
74,624 |
18,752,511 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-12-16 |
4 |
A |
$248.26 |
$21,244,456 |
D/D |
85,573 |
18,677,887 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-12-15 |
4 |
A |
$239.31 |
$16,258,723 |
D/D |
67,941 |
18,592,314 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$248.49 |
$14,757,578 |
D/D |
59,390 |
18,524,373 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-08-24 |
4 |
A |
$239.10 |
$14,199,906 |
D/D |
59,390 |
18,464,983 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-08-21 |
4 |
A |
$230.18 |
$14,772,012 |
D/D |
64,176 |
18,405,593 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-08-20 |
4 |
A |
$234.99 |
$15,080,981 |
D/D |
64,176 |
18,341,417 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-08-19 |
4 |
A |
$234.88 |
$15,073,454 |
D/D |
64,176 |
18,277,241 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-08-18 |
4 |
A |
$230.18 |
$9,207,188 |
D/D |
40,000 |
18,213,065 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-07-15 |
4 |
A |
$14.23 |
$421,442,751 |
D/D |
29,614,832 |
236,249,845 |
0 |
- |
|
| BGNE |
Beigene Ltd |
10% Owner |
– – • |
2020-01-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,635,013 |
|
% |
|
| KZR |
Kezar Life Sciences, Inc. |
10% Owner |
– – • |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,121,384 |
1,121,384 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
10% Owner |
– – • |
2013-06-05 |
4 |
B |
$15.00 |
$249,990 |
D/D |
16,666 |
334,126 |
2.45 |
- |
|
| EPZM |
Epizyme, Inc. |
10% Owner |
– – • |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
317,460 |
317,460 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
